Latest News

 

AptarGroup Reports Increased First Quarter Revenue and Earnings

Crystal Lake, Illinois, April 27, 2017 — AptarGroup, Inc. (NYSE:ATR) today announced increased revenue, net income and earnings per share for the first quarter of 2017. In addition, AptarGroup announced its continued investment in the field of connected electronic drug delivery devices.

First Quarter Summary

  • Reported sales grew 3%; growth in Beauty + Home and Pharma offset decline in Food + Beverage
  • Excluding the negative impact from changes in foreign currency exchange rates and the positive contribution from an acquisition, core sales also increased 3%
  • Reported earnings per share were $0.81, which includes a $0.04 tax benefit not included in previous first quarter guidance, compared to $0.67 in the prior year (+21%); when adjusting for special items and changes in currency exchange rates, comparable earnings per share for the prior year were $0.74 (+9%)
  • Earnings per share for both the current and prior year included certain tax benefits amounting to approximately $0.04 in each respective period
  • Received the first order for European Medicines Agency (EMA)-approved integrated electronic nasal lockout device (Aptar’s eLockout)
  • Acquired 20% minority ownership position in Kali Care, a Silicon Valley-based technology company, which provides digital monitoring systems for ophthalmic medications

Download the full press release.

April 27, 2017

Aptar's Dispensers: Bringing the "Three C's" to Dish Care

Crystal Lake, Illinois, April 27, 2017 — AptarGroup, Inc. (NYSE:ATR) today announced increased revenue, net income and earnings per share for the first quarter of 2017. In addition, AptarGroup announced its continued investment in the field of connected electronic drug delivery devices.

First Quarter Summary

  • Reported sales grew 3%; growth in Beauty + Home and Pharma offset decline in Food + Beverage
  • Excluding the negative impact from changes in foreign currency exchange rates and the positive contribution from an acquisition, core sales also increased 3%
  • Reported earnings per share were $0.81, which includes a $0.04 tax benefit not included in previous first quarter guidance, compared to $0.67 in the prior year (+21%); when adjusting for special items and changes in currency exchange rates, comparable earnings per share for the prior year were $0.74 (+9%)
  • Earnings per share for both the current and prior year included certain tax benefits amounting to approximately $0.04 in each respective period
  • Received the first order for European Medicines Agency (EMA)-approved integrated electronic nasal lockout device (Aptar’s eLockout)
  • Acquired 20% minority ownership position in Kali Care, a Silicon Valley-based technology company, which provides digital monitoring systems for ophthalmic medications

Download the full press release.

Connect with Aptar Pharma at RDD Europe 2017 - April 25-28 in Ant...

Crystal Lake, Illinois, April 27, 2017 — AptarGroup, Inc. (NYSE:ATR) today announced increased revenue, net income and earnings per share for the first quarter of 2017. In addition, AptarGroup announced its continued investment in the field of connected electronic drug delivery devices.

First Quarter Summary

  • Reported sales grew 3%; growth in Beauty + Home and Pharma offset decline in Food + Beverage
  • Excluding the negative impact from changes in foreign currency exchange rates and the positive contribution from an acquisition, core sales also increased 3%
  • Reported earnings per share were $0.81, which includes a $0.04 tax benefit not included in previous first quarter guidance, compared to $0.67 in the prior year (+21%); when adjusting for special items and changes in currency exchange rates, comparable earnings per share for the prior year were $0.74 (+9%)
  • Earnings per share for both the current and prior year included certain tax benefits amounting to approximately $0.04 in each respective period
  • Received the first order for European Medicines Agency (EMA)-approved integrated electronic nasal lockout device (Aptar’s eLockout)
  • Acquired 20% minority ownership position in Kali Care, a Silicon Valley-based technology company, which provides digital monitoring systems for ophthalmic medications

Download the full press release.

April 21, 2017

AptarGroup Declares Quarterly Dividend

Crystal Lake, Illinois, April 27, 2017 — AptarGroup, Inc. (NYSE:ATR) today announced increased revenue, net income and earnings per share for the first quarter of 2017. In addition, AptarGroup announced its continued investment in the field of connected electronic drug delivery devices.

First Quarter Summary

  • Reported sales grew 3%; growth in Beauty + Home and Pharma offset decline in Food + Beverage
  • Excluding the negative impact from changes in foreign currency exchange rates and the positive contribution from an acquisition, core sales also increased 3%
  • Reported earnings per share were $0.81, which includes a $0.04 tax benefit not included in previous first quarter guidance, compared to $0.67 in the prior year (+21%); when adjusting for special items and changes in currency exchange rates, comparable earnings per share for the prior year were $0.74 (+9%)
  • Earnings per share for both the current and prior year included certain tax benefits amounting to approximately $0.04 in each respective period
  • Received the first order for European Medicines Agency (EMA)-approved integrated electronic nasal lockout device (Aptar’s eLockout)
  • Acquired 20% minority ownership position in Kali Care, a Silicon Valley-based technology company, which provides digital monitoring systems for ophthalmic medications

Download the full press release.

April 20, 2017

Airless Dispensing Solution for Face Zone Skin Serum by Dr Irena ...

Crystal Lake, Illinois, April 27, 2017 — AptarGroup, Inc. (NYSE:ATR) today announced increased revenue, net income and earnings per share for the first quarter of 2017. In addition, AptarGroup announced its continued investment in the field of connected electronic drug delivery devices.

First Quarter Summary

  • Reported sales grew 3%; growth in Beauty + Home and Pharma offset decline in Food + Beverage
  • Excluding the negative impact from changes in foreign currency exchange rates and the positive contribution from an acquisition, core sales also increased 3%
  • Reported earnings per share were $0.81, which includes a $0.04 tax benefit not included in previous first quarter guidance, compared to $0.67 in the prior year (+21%); when adjusting for special items and changes in currency exchange rates, comparable earnings per share for the prior year were $0.74 (+9%)
  • Earnings per share for both the current and prior year included certain tax benefits amounting to approximately $0.04 in each respective period
  • Received the first order for European Medicines Agency (EMA)-approved integrated electronic nasal lockout device (Aptar’s eLockout)
  • Acquired 20% minority ownership position in Kali Care, a Silicon Valley-based technology company, which provides digital monitoring systems for ophthalmic medications

Download the full press release.

April 17, 2017

Quick Flip by Aptar: The Next Generation in Flexible Dispensing

Crystal Lake, Illinois, April 27, 2017 — AptarGroup, Inc. (NYSE:ATR) today announced increased revenue, net income and earnings per share for the first quarter of 2017. In addition, AptarGroup announced its continued investment in the field of connected electronic drug delivery devices.

First Quarter Summary

  • Reported sales grew 3%; growth in Beauty + Home and Pharma offset decline in Food + Beverage
  • Excluding the negative impact from changes in foreign currency exchange rates and the positive contribution from an acquisition, core sales also increased 3%
  • Reported earnings per share were $0.81, which includes a $0.04 tax benefit not included in previous first quarter guidance, compared to $0.67 in the prior year (+21%); when adjusting for special items and changes in currency exchange rates, comparable earnings per share for the prior year were $0.74 (+9%)
  • Earnings per share for both the current and prior year included certain tax benefits amounting to approximately $0.04 in each respective period
  • Received the first order for European Medicines Agency (EMA)-approved integrated electronic nasal lockout device (Aptar’s eLockout)
  • Acquired 20% minority ownership position in Kali Care, a Silicon Valley-based technology company, which provides digital monitoring systems for ophthalmic medications

Download the full press release.

April 13, 2017
aptar.com |  Email |  815 477 0424
Privacy Policy |  Terms & Conditions of Sales